Global Health Limited (Medanta) on Thursday announced its unaudited consolidated financial results for the quarter ending 30th September, 2024. The healthcare company posted a profit growth of 4.52 per cent for the fiscal second quarter at Rs 130.82 crore in comparison to Rs 125.16 crore during the corresponding quarter of FY24.
The company reported revenue from operations at Rs 956.56 crore, up 12.48 per cent as against Rs 850.45 crore during the same period of previous financial year. The company EBITDA stood at Rs 228.2 crore, up 4 per cent year-on-year.
During the quarter, 52 bed were added at Lucknow and 66 beds at Patna resulting in total bed addition of 118 beds in Q2 FY25. Average occupied bed days increased by 9.1% y-o-y, with strong occupancy of 64.3% on increased bed capacity. In-patients count increased by 8.8% y-o-y; Out-patients count increased by 6.6% y-o-y, the company stated.
Also Read EPFO reports 7.8% increase in claims settled, 7.6% growth in subscribers: Labour Ministry PSU Index falls 13 per cent from its peak Aditya Birla Fashion and Retail posts widened Q2 loss of Rs 214.70 crore, revenue up 12.9% YoY Trent Q2 Results: Profit rises by 46.9% at Rs 335.06 crore but misses estimates
Matured hospitals revenue was Rs. 6,88.2 crore, strong growth of 13.5% y-o-y and 7.8% on q-o-q basis. EBITDA was Rs. 1,73.9 crore, growth of 12.5% y-o-y and 9.4% on q-o-q basis. Developing hospitals revenue was Rs. 2,754 million, growth of 4.2% y-o-y and 16.2% on q-o-q basis. EBITDA was Rs. 823 million, down by 8.2% y-o-y and strong growth of 41.7% on q-o-q basis
Also ReadSupreme Court rejects plea to mandate doctors to inform patients about drug side-effects
During the quarter, International Patients Revenue was Rs. 51.3 crore. Out-patient pharmacy (Hospital + Retail) continues to register strong growth. Revenue increased by 24.5% from Rs. 29.8 crore in Q2 FY24 to Rs. 371 million in Q2 FY25.
“We are pleased to report a strong performance this quarter, achieving our highest-ever quarterly Revenue and EBITDA. Growth momentum was robust across our network hospitals, as we continue to invest in cutting-edge technologies, enhance clinical capabilities through the on-boarding of senior clinicians, and expand our network by adding more beds. I am also excited to announce that Medanta has recently signed an Operations and Management agreement to operate and manage a state-of-the-art,
» Read More
